Rapid tests for sexually transmitted diseases

被引:19
作者
Gaydos C.A. [1 ]
机构
[1] Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205
关键词
Bacterial Vaginosis; Chlamydia Trachomatis; Rapid Test; Neisseria Gonorrhoeae; Gonorrhea;
D O I
10.1007/s11908-006-0007-7
中图分类号
学科分类号
摘要
Many molecular diagnostic tests for sexually transmitted diseases (STDs) have been described recently but are not often accessible to clinicians in practice. There is a need for rapid, easy-to-perform, and accurate diagnostic tests for clinicians, especially for use in developing countries, where sophisticated laboratory support is often unavailable. Rapid tests, often termed "point-of-care" (POC) tests, can be performed in less than an hour in the doctor's office, clinic, or in a field setting. If simple laboratory equipment is available, a health care worker or clinician can make an immediate diagnosis of a STD. Progress has been made in the development of POC tests for HIV, syphilis, trichomonas, and bacterial vaginosis, but more work is needed for chlamydia and gonorrhea. Improvements in POCs will allow for faster treatment or provision of interventions in infected persons, in order to prevent transmission to partners or infants, thereby enabling effective control efforts for STDs. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:115 / 124
页数:9
相关论文
共 67 条
[1]  
Gaydos C.A., Rompalo A.M., The use of urine and self-obtained vaginal swabs for the diagnosis of sexually transmitted diseases, Current Infect Dis Reports, 4, pp. 148-157, (2002)
[2]  
Gaydos C.A., Quinn T.C., Urine nucleic acid amplification tests for the diagnosis of sexually transmitted infections in clinical practice, Curr Opin Infect Dis, 18, pp. 55-66, (2005)
[3]  
Gaydos C.A., Nucleic acid amplification tests for gonorrhea and chlamydia: Practice and applications, Sexually Transmitted Infections, pp. 367-386, (2005)
[4]  
Gravitt P.E., Peyton C.L., Alessi T.Q., Et al., Improved amplification of genital human papillomaviruses, J Clin Microbiol, 38, pp. 357-361, (2000)
[5]  
Gravitt P.E., Lacey Jr. J.V., Brinton L.A., Et al., Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction, Cancer Epideriol Biomarkers Prev, 10, pp. 95-100, (2001)
[6]  
Gravitt P.E., Jamshidi R., Diagnosis and management of oncogenic cervical human papillomavirus infection, Sexually Transmitted Infections, pp. 439-458, (2005)
[7]  
Hardick J., Yang S., Lin L., Et al., Use of the Roche LightCycler Instrument in a Real-T time PCR for Trichomonas vaginalis in urine samples from females and males, J Clin Microbiol, 41, pp. 5619-5622, (2003)
[8]  
Kaydos-Daniels S.C., Miller W.C., Hoffman I., Et al., Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men, J Clin Microbiol, 41, pp. 318-323, (2003)
[9]  
Jensen J.S., Bjornelius E., Dohn B., Lidbrink P., Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic, Sex Transm Dis, 31, pp. 499-507, (2004)
[10]  
Palmer H.M., Higgins S.P., Herring A.J., Kingston M.A., Use of PCR in the diagnosis of early syphilis in the United Kingdom, Sex Transm Infect, 79, pp. 479-483, (2003)